Acute Dialytic Support for the Critically III: Intermittent Hemodialysis versus Continuous Arteriovenous Hemodiafiltration
The DOI matches its Crossref record.
Abstract
There is still debate about whether continuous renal replacement therapy is superior to intermittent hemodialysis (IHD) as dialytic support for the critically ill patient with acute renal failure, mainly because of lack of comparative data. We sought to address this issue by reviewing the medical records of such patients admitted to a single surgical intensive care unit treated with either continuous arteriovenous hemodiafiltration (CAVHD) or IHD between January 1, 1986, and August 31, 1993. Of 94 consecutive patients who received dialytic support for severe acute renal failure, 34 (36%) patients were treated with IHD and 60 (64%) patients with CAVHD. The patients were comparable in terms of age or gender and represented a similar case mix. Patients treated with CAVHD were more severely ill as manifested by a lower mean arterial pressure (75 ± 3 vs. 86 ± 5 mm Hg; p < 0.05), higher Apache II score (26.5 ± 0.5 vs. 22.2 ± 0.3; p < 0.05), and a higher number of organ system failures (3.4 ± 0.2 vs. 2.6 ± 0.3; p < 0.05). Despite greater illness severity and a higher probability of death (55 ± 2.6 vs. 33 ± 2.5%; p < 0.0001), in those treated with CAVHD, no difference in outcome was observed between groups: CAVHD 26/60 (43%) vs. IHD 20/34 (59%; NS). The mean Apache II score of patients treated with CAVHD who survived was similar to that of patients treated with IHD who died (24.5 ± 0.3 vs. 24.2 ± 0.4; NS). CAVHD was associated with improved hemodynamic stability, better control of fluid balance and biochemistry, increased nutritional intake, and a shorter duration of acute renal failure (p < 0.05). Our data suggest that CAVHD offers several distinct advantages over IHD which may translate in improved survival, particularly in the more severely ill patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,772
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Alhazzani, W., Møller, M. H., Arabi, Y. M., Loeb, M., Gong, M. N., Fan, E., Oczkowski, S., Levy, M. M., Derde, L., Dzierba, A., et al. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004363 · Cited by 1,565
Vinsonneau, C., Camus, C., Combes, A., Costa de Beauregard, M. A., Klouche, K., Boulain, T., Pallot, J.-L., Chiche, J.-D., Taupin, P., Landais, P., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69111-3 · Cited by 685
A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure
Mehta, R. L., for the Collaborative Group for Treatment of ARF in the ICU, Mcdonald, B., Gabbai, F. B., Pahl, M., Pascual, M. T. A., Farkas, A., & Kaplan, R. M. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0600031154.x · Cited by 658
Continuous versus intermittent renal replacement therapy: A meta-analysis.
A. Kellum, J., C. Angus, D., P. Johnson, J., Leblanc, M., Griffin, M., Ramakrishnan, N., & T. Linde-Zwirble, W. (2002) · Intensive Care Medicine · doi:10.1007/s00134-001-1159-4 · Cited by 369
Clermont, G., Acker, C. G., Angus, D. C., Sirio, C. A., Pinsky, M. R., & Johnson, J. P. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00509.x · Cited by 366
Ronco, C., Tetta, C., Mariano, F., Wratten, M. L., Bonello, M., Bordoni, V., Cardona, X., Inguaggiato, P., Pilotto, L., D’Intini, V., et al. (2003) · Artificial Organs · doi:10.1046/j.1525-1594.2003.07289.x · Cited by 356
Brochard, L., Abroug, F., Brenner, M., Broccard, A. F., Danner, R. L., Ferrer, M., Laghi, F., Magder, S., Papazian, L., Pelosi, P., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200711-1664st · Cited by 319
Tonelli, M., Manns, B., & Feller-Kopman, D. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.36318 · Cited by 308
Kumar, V. A., Craig, M., Depner, T. A., & Yeun, J. Y. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.8973 · Cited by 264
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Critical Care Medicine · doi:10.1097/01.ccm.0000298158.12101.41 · Cited by 9
Metadata
- Authors
- van Bommel, E. F. H., Bouvy, N. D., So, K. L., Zietse, R., Vincent, H. H., Bruining, H. A., & Weimar, W.
- Venue
- American Journal of Nephrology
- Publisher
- S. Karger AG
- Published
- 1995
- Volume
- 15
- Issue
- 3
- Pages
- 192-200
- ISSN
- 0250-8095 (ISSN-L)
- 1421-9670
- OpenAlex
- W2027534721
- Cited by
- 139
- References
- 0
- FWCI
- 8.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.